| Entry |
|
|---|
| Name |
Zafirlukast (JAN/USAN/INN);
Accolate (TN)
|
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C31H33N3O6S
|
|---|
| Exact mass |
575.209
|
|---|
| Mol weight |
575.6752
|
|---|
| Structure |
     |
|---|
| Activity |
Anti-asthmatic [leukotriene antagonist] [DS: H00079]
|
|---|
| Remark |
Same as: Therapeutic category: ATC code: |
|---|
| Target |
cysteinyl leukotriene receptor 1 (CYSLTR1) antagonist [HSA: 10800] [KO: K04322] |
|---|
| Pathway |
hsa04020 Calcium signaling pathway
hsa04080 Neuroactive ligand-receptor interaction | |
|
|---|
| Interaction |
CYP inhibition: CYP2C9 [HSA: 1559]
 |
|---|
| Structure map |
| Eicosanoids | | Eicosanoid receptor agonists/antagonists |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
44 Allergic agents
449 Miscellaneous
4490 Miscellaneous
D00411 Zafirlukast (JAN/USAN/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DC Leukotriene receptor antagonists
R03DC01 Zafirlukast
D00411 Zafirlukast (JAN/USAN/INN)
USP drug classification [BR:br08302]
Respiratory Tract Agents
Antileukotrienes
Zafirlukast
D00411 Zafirlukast (JAN/USAN/INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Cysteinyl leukotriene
cysteinyl leukotriene receptor 1 [HSA:10800] [KO:K04322]
Zafirlukast [ATC:R03DC01]
D00411 Zafirlukast (JAN/USAN/INN)
 |
|---|
| Other DBs |
CAS: 107753-78-6 PubChem: DrugBank: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 41
1 C8y C 26.8135 -18.7539
2 C8y C 25.4863 -18.3350
3 C8y C 26.8200 -20.1521
4 C8x C 28.0184 -18.0581
5 C1b C 24.2816 -17.6329
6 C8x C 24.6745 -19.4626
7 N4y N 25.4992 -20.5900
8 C8x C 28.0248 -20.8413
9 C8y C 29.2295 -18.7539
10 C8y C 23.0702 -18.3287
11 C1a C 25.0803 -21.9303
12 C8x C 29.2295 -20.1455
13 N1b N 30.4345 -18.0452
14 C8y C 21.8526 -17.6200
15 C8x C 23.0702 -19.7268
16 C7a C 31.6522 -18.7474
17 C8x C 20.6413 -18.3221
18 O2a O 21.8589 -16.2218
19 C8x C 21.8526 -20.4226
20 O7a O 32.8635 -18.0387
21 O6a O 31.6522 -20.1521
22 C8y C 20.6413 -19.7268
23 C1a C 20.6413 -15.5195
24 C1y C 34.0811 -18.7474
25 C5a C 19.4236 -20.4226
26 C1x C 34.2356 -20.1455
27 C1x C 35.3696 -18.1805
28 N1b N 18.2123 -19.7268
29 O5a O 19.4236 -21.8271
30 C1x C 35.6080 -20.4355
31 C1x C 36.3038 -19.2179
32 S4a S 17.0010 -20.4226
33 C8y C 15.7962 -19.7268
34 O3c O 16.0023 -21.4213
35 O3c O 17.9931 -21.4213
36 C8y C 15.7962 -18.3221
37 C8x C 14.5849 -20.4226
38 C8x C 14.5849 -17.6200
39 C1a C 17.0075 -17.6200
40 C8x C 13.3673 -19.7268
41 C8x C 13.3673 -18.3221
BOND 45
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 2 6 2
6 3 7 1
7 3 8 1
8 4 9 2
9 5 10 1
10 7 11 1
11 8 12 2
12 9 13 1
13 10 14 1
14 10 15 2
15 13 16 1
16 14 17 2
17 14 18 1
18 15 19 1
19 16 20 1
20 16 21 2
21 17 22 1
22 18 23 1
23 20 24 1
24 22 25 1
25 24 26 1
26 24 27 1
27 25 28 1
28 25 29 2
29 26 30 1
30 27 31 1
31 28 32 1
32 32 33 1
33 32 34 2
34 32 35 2
35 33 36 1
36 33 37 2
37 36 38 2
38 36 39 1
39 37 40 1
40 38 41 1
41 6 7 1
42 9 12 1
43 19 22 2
44 30 31 1
45 40 41 2
|
|---|
